MONDOGEN
MondoGen is a biotechnology company that focuses exclusively on the development of liver-specific gene therapy systems. Based on a version of the hepatitis B virus that is unable to cause disease, MondoGen's technology enables highly efficient transfer of genes into liver cells. MondoGen is applying its technology to develop therapeutics against viral, malignant and inherited liver disorders.
MONDOGEN
Industry:
Biotechnology Medical Therapeutics
Address:
Munich, Bayern, Germany
Country:
Germany
Status:
Active
Similar Organizations
Astex
Astex is a UK-based biotechnology company that discovers and develops novel small molecule therapeutics.
Centauri Therapeutics
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Neumedicines
Neumedicines is a biotechnology company that focuses on the development of protein therapeutics.
More informations about "MondoGen"
MondoGen - Crunchbase Company Profile & Funding
MondoGen is a biotechnology company that focuses exclusively on the development of liver-specific gene therapy systems. Based on a version of the hepatitis B virus that is unable to โฆSee details»
MondoGen - Crunchbase
MondoGen is a biotechnology company that focuses exclusively on the development of liver-specific gene therapy systems.See details»
HepaVec AG acquires MondoGen - 1999-11-08 - Crunchbase
Acquired Organization: MondoGen MondoGen is a biotechnology company that focuses exclusively on the development of liver-specific gene therapy systems. Acquiring Organization:See details»
MondoGen - Drug pipelines, Patents, Clinical trials - Synapse
Explore MondoGen with its drug pipeline, therapeutic area, technology platform, .See details»
NutriciaMetabolics - Monogenยฎ
A milk protein-based powdered formula, low in fat, and high in medium chain triglycerides (MCT) for the dietary management of disorders requiring a low long chain triglycerides (LCT), high medium chain triglycerides (MCT) diet for โฆSee details»
HepaVec acquires majority stake in MondoGen - | BioWorld
Nov 10, 1999ย ยท Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, โฆSee details»
Indications: MONOGENยฎ - Nutricia Metabolics
Concentration Powder Water Final Volume 22 kcal/30 mL 16.8 g 90 mL 100 mL (0.74 kcal/mL) (3 Scoops) (3 fl oz)See details»
Kidney Foundation - The Kidney Foundation of Canada
Transformative gene-based medicines for patients with rare diseases are now aiming to cure diseases at the molecular level using innovative gene-editing tools.See details»
Monarch Initiative - Mondo Disease Ontology
Mondo is a semi-automatically constructed ontology that merges in multiple disease resources to yield a coherent merged ontology. See sources here. Original versions of Mondo were โฆSee details»
Monogen - Nutricia UK
Monogen is a nutritionally complete, low fat, whole whey protein powdered feed, low in long chain triglycerides (LCT) and high in medium chain triglycerides (MCT), containing linoleic acid (LA) โฆSee details»
HepaVec AG - Funding, Financials, Valuation & Investors
HepaVec AG has acquired MondoGen on Nov 8, 1999. in funding over 2 rounds. Their latest funding was raised on May 8, 2000 from a Series A round. Which funding types raised the โฆSee details»
MONOGEN - Nutricia
A nutritionally complete low fat, whole whey protein powdered feed low in long chain triglycerides (LCT) and high in medium chain triglycerides (MCT).See details»
Monogen - Paediatrics - Nutricia
Monogen is a nutritionally complete, low fat, protein containing powdered feed, low in long chain triglycerides (LCT) and high in medium chain triglycerides (MCT).See details»
mondoGEN AG :: Switzerland :: OpenCorporates
Free and open company data on Switzerland company mondoGEN AG (company number 861643), Mรผrgstrasse, 18, Stans, 6370See details»
UPDATED FORMULATION โ SAME MCT - Nutricia Learning Center
We are writing to inform you about upcoming formulation changes for our medical food product Monogenยฎ. Monogen is a milk protein-based powder that is high in medium chain triglycerides โฆSee details»
New Metabolic Fact Sheet Compendium 2019 - Nutricia
Each level scoop (5.6g) of Monogen requires 30ml to yield the recommended feed concentration of 16.8%. The dosage should be determined by a clinician or dietitian only and is dependent โฆSee details»
Monarch Disease Ontology (MonDO) - ClinGen - Clinical Genome
Description: This video describes the Monarch Disease Ontology (MonDO). Of note, MonDO IDs are required for describing the disease entity in the ClinGen Gene and Variant Curation โฆSee details»
A milk-based powdered formula containing protein as a โฆ
Concentration Powder Water Final Volume 22 kcal/30 mL 16.8 g 90 mL 100 mL (0.74 kcal/mL) (3 Scoops) (3 ๆฐ oz)See details»
MTร Mondo
Mondo is an Estonian organisation aiming to reduce global inequality. Mondo focuses on five programmes in 13 countries. Read about us here. SUPPORT MONDO'S ACTIVITIES โฆSee details»
About Mondo | MTร Mondo
Mondo is an Estonian organisation aiming to reduce global inequality. Mondo operates in 12 countries abroad and in Estonia. Mondo focuses on education/health, livelihood, โฆSee details»